BI-L 239 is an inhibition of 5-lipoxygenase products that cause bronchoconstriction.

125722-16-9

C16H15FO

242.29

Enofelast;BI-L-239;BIL239;BI-L 239

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years